Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
235 studies found for:    Ankylosing Spondylitis
Show Display Options
RSS Create an RSS feed from your search for:
Ankylosing Spondylitis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: adalimumab
2 Completed Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
3 Completed
Has Results
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
4 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Etanercept (Enbrel);   Other: Placebo
5 Completed
Has Results
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: etanercept/placebo
6 Active, not recruiting Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:
7 Completed Safety and Effectiveness of Adalimumab (Humira) in Patients With Ankylosing Spondylitis in Clinical Routine
Condition: Ankylosing Spondylitis
Intervention:
8 Completed
Has Results
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: sulphasalazine (SSZ)
9 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
10 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
11 Completed
Has Results
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
12 Recruiting A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
13 Completed
Has Results
Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab;   Drug: Golimumab (placebo group)
14 Completed
Has Results
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
15 Completed Efficacy of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: AIN457;   Drug: ARIN457
16 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
17 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
18 Completed
Has Results
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
19 Completed
Has Results
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Treatment switching
20 Completed
Has Results
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: golimumab;   Biological: Golimumab (CNTO 148); placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years